1. Ragaini, Simone, Wagner, Sarah, Marconi, Giovanni, Rutella, Sergio, Curti, Antonio. . An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. In Blood advances, 6, 87-99. doi:10.1182/bloodadvances.2021004878. https://pubmed.ncbi.nlm.nih.gov/34535017/
2. Liang, Xiaowei, Gao, Hongwei, Xiao, Jian, Yang, Shilin, Yao, Chun. 2023. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma. In Frontiers in immunology, 14, 1185985. doi:10.3389/fimmu.2023.1185985. https://pubmed.ncbi.nlm.nih.gov/37334368/
3. Oyoshi, Hidekazu, Du, Junyan, Sakai, Shunsuke A, Suzuki, Yutaka, Kageyama, Shun-Ichiro. 2023. Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma. In Science advances, 9, eadh9069. doi:10.1126/sciadv.adh9069. https://pubmed.ncbi.nlm.nih.gov/38091397/
4. Bartok, Osnat, Pataskar, Abhijeet, Nagel, Remco, Samuels, Yardena, Agami, Reuven. 2020. Anti-tumour immunity induces aberrant peptide presentation in melanoma. In Nature, 590, 332-337. doi:10.1038/s41586-020-03054-1. https://pubmed.ncbi.nlm.nih.gov/33328638/
5. Zhao, Feifan, Huang, Yaoyao, Ji, Junzhi, Yi, Lin, Fan, Shuangqi. 2024. IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling. In Journal of virology, 98, e0045824. doi:10.1128/jvi.00458-24. https://pubmed.ncbi.nlm.nih.gov/38814067/
6. Lee, Alexander, Kanuri, Navya, Zhang, Yuanhao, Li, Ellen, Ciorba, Matthew A. 2014. IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype. In PloS one, 9, e115848. doi:10.1371/journal.pone.0115848. https://pubmed.ncbi.nlm.nih.gov/25541686/
智鼠故事 
